Cramer: Hope for biotech in the blast zone

Jim Cramer goes off the charts to determine if the biotech sector could come roaring back.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.